Bionet (1784) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.013x

Based on the latest financial reports, Bionet (1784) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$28.46 Million ≈ $896.68K USD) by net assets (NT$2.26 Billion ≈ $71.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bionet defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Bionet - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Bionet's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bionet Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bionet ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Garuda Metalindo Tbk PT JK:BOLT	-0.092x
Eimco Elecon (India) Limited NSE:EIMCOELECO	0.013x
Nava Nakorn Public Company Limited BK:NNCL	0.023x
Tung Ho Textile Co Ltd TW:1414	0.013x
Eagle Cold Storage Enterprise Co Ltd TWO:8905	0.038x
Icares Medicus Inc TWO:6612	-0.002x
GOLCONDA GOLD LTD F:Y87	0.075x
Calitech Co Ltd TWO:6532	0.019x

Annual Cash Flow Conversion Efficiency for Bionet (2017–2025)

The table below shows the annual cash flow conversion efficiency of Bionet from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Bionet market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.26 Billion ≈ $71.12 Million	NT$148.04 Million ≈ $4.66 Million	0.066x	-10.97%
2024-12-31	NT$2.40 Billion ≈ $75.48 Million	NT$176.49 Million ≈ $5.56 Million	0.074x	-17.13%
2023-12-31	NT$1.72 Billion ≈ $54.26 Million	NT$153.09 Million ≈ $4.82 Million	0.089x	+24.41%
2022-12-31	NT$1.32 Billion ≈ $41.74 Million	NT$94.65 Million ≈ $2.98 Million	0.071x	+577.37%
2021-12-31	NT$1.32 Billion ≈ $41.45 Million	NT$13.88 Million ≈ $437.23K	0.011x	-81.54%
2020-12-31	NT$1.29 Billion ≈ $40.62 Million	NT$73.66 Million ≈ $2.32 Million	0.057x	+2698.56%
2019-12-31	NT$1.31 Billion ≈ $41.19 Million	NT$2.67 Million ≈ $84.09K	0.002x	+121.09%
2018-12-31	NT$1.34 Billion ≈ $42.22 Million	NT$-12.97 Million ≈ $-408.78K	-0.010x	+46.69%
2017-12-31	NT$1.37 Billion ≈ $43.21 Million	NT$-24.91 Million ≈ $-784.83K	-0.018x	--

About Bionet

TWO:1784 Taiwan Diagnostics & Research

Market Cap

$107.77 Million

NT$3.42 Billion TWD

Market Cap Rank

#18908 Global

#1067 in Taiwan

Share Price

NT$68.00

Change (1 day)

-4.23%

52-Week Range

NT$64.60 - NT$115.50

All Time High

NT$161.50